Laman UtamaRGLS • NASDAQ
add
Regulus Therapeutics Inc
$8.22
Selepas Waktu Dagangan:(0.12%)-0.010
$8.21
Tutup: 6 Jun, 5:42:27 PTG GMT-4 · USD · NASDAQ · Penafian
Tutup sebelumnya
$8.10
Julat hari
$8.07 - $8.28
Julat tahun
$0.83 - $8.28
Permodalan pasaran
569.10J USD
Bilangan Purata
2.38J
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
NASDAQ
Berita pasaran
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (USD) | Mac 2025info | Perubahan T/T |
|---|---|---|
Hasil | — | — |
Perbelanjaan pengendalian | 3.72J | 33.49% |
Pendapatan bersih | -9.63J | -13.76% |
Margin untung bersih | — | — |
Pendapatan bagi setiap syer | -0.15 | 48.28% |
EBITDA | -10.45J | -19.53% |
Kadar cukai berkesan | — | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (USD) | Mac 2025info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 65.37J | -32.99% |
Jumlah aset | 74.83J | -34.44% |
Jumlah liabiliti | 5.80J | -11.48% |
Jumlah ekuiti | 69.03J | — |
Syer tertunggak | 69.23J | — |
Harga kepada buku | 7.79 | — |
Pulangan pada aset | -33.14% | — |
Pulangan pada modal | -35.63% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (USD) | Mac 2025info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | -9.63J | -13.76% |
Tunai daripada operasi | -10.61J | -21.40% |
Tunai daripada pelaburan | 21.50J | 127.37% |
Tunai daripada pembiayaan | 45.00K | -99.95% |
Perubahan bersih dalam tunai | 10.93J | 87.87% |
Aliran tunai bebas | -6.34J | -1.31% |
Perihal
Regulus Therapeutics Inc. is a clinical stage biopharmaceutical company focused on the development of first-in-class drugs that target microRNAs to treat a broad range of diseases. Regulus was established in September 2007 by Alnylam Pharmaceuticals and Isis Pharmaceuticals. In April 2025, Novartis announced that it had entered into an agreement to acquire Regulus. Wikipedia
Diasaskan
Sep 2007
Tapak web
Pekerja
34
